Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Financial giants have made a conspicuous bearish move on Stryker. Our analysis of options history for Stryker (NYSE:SYK) revealed 8 unusual trades.
Delving into the details, we found 25% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $424,828, and 3 were calls, valued at $144,240.
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $320.0 to $340.0 for Stryker during the past quarter.
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Stryker's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Stryker's significant trades, within a strike price range of $320.0 to $340.0, over the past month.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
SYK | PUT | SWEEP | BULLISH | 01/17/25 | $20.6 | $19.7 | $19.7 | $320.00 | $220.6K | 406 | 143 |
SYK | CALL | SWEEP | BEARISH | 01/17/25 | $26.2 | $24.9 | $24.9 | $340.00 | $74.7K | 1.0K | 45 |
SYK | PUT | SWEEP | BEARISH | 01/17/25 | $25.1 | $24.1 | $25.1 | $330.00 | $65.2K | 226 | 46 |
SYK | PUT | SWEEP | BEARISH | 01/17/25 | $29.6 | $28.6 | $29.6 | $340.00 | $50.3K | 254 | 17 |
SYK | PUT | SWEEP | BEARISH | 01/17/25 | $24.2 | $23.4 | $24.2 | $330.00 | $48.4K | 226 | 20 |
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Following our analysis of the options activities associated with Stryker, we pivot to a closer look at the company's own performance.
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $390.5.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Stryker options trades with real-time alerts from Benzinga Pro.
Posted In: SYK